- About the Center
- Patient Care
- Community Outreach
- Academic Programs
- News & Media
University of Arizona Cancer Center founding Director Sydney E. Salmon, MD, has been named an “Oncology Luminary” by the American Society of Clinical Oncology in celebration of its 50th anniversary.
Truly groundbreaking cancer research is reserved for those who find new ways to look at the disease. Ghassan Mouneimne, PhD, is doing just that.
From genome sequencing to cellular biology to clinical application, the team at the UA Cancer Center approaches its research from all angles to deliver the most forward-thinking, state-of-the-art cancer care.
A new drug that is being researched at the University of Arizona Cancer Center aimed at pancreatic tumors may be delivered more effectively by being encapsulated by nanoparticles.
S1008 is a clinical trial to test whether an exercise and diet weight loss program can help overweight female colon or rectal cancer survivors reach a healthy body weight.
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph’s Hospital and Medical Center has been published in the New England Journal of Medicine.
The University of Arizona Cancer Center has named Ali McBride, PharmD, MS, BCPS, clinical coordinator, where he will collaborate with the director of pharmacy, oncology services and other members of the healthcare team to improve the services delivered by the oncology pharmacy team.
A $2.8 million grant will fund a study to determine the cancer risk reduction effects of Metformin in overweight and obese premenopausal women.